Stocks In the News: Check out the companies making the biggest headlines before the opening bell
Results on October 25: Tech Mahindra, HDFC Asset Management Company, Aditya Birla Sun Life AMC, ANG Lifesciences India, Aurionpro Solutions, Ceat, Coforge, Colgate-Palmolive (India), CSB Bank, Dwarikesh Sugar Industries, Gujarat Mineral Development Corporation, Goodluck India, Home First Finance Company India, ICRA, Indus Towers, Jagran Prakashan, Kansai Nerolac Paints, Karda Constructions, LKP Securities, Maharashtra Scooters, Mangalam Organics, Newgen Software Technologies, Orient Cement, Prakash Industries, Quick Heal Technologies, Ramco Cements, Shriram Asset Management, SRF, Suven Life Sciences, and Welcure Drugs & Pharmaceuticals.
Reliance Industries: The company reported sharply higher consolidated profit at Rs 15,479 crore in Q2FY22 against Rs 10,602 crore in Q2FY21, revenue jumped to Rs 1,74,104 crore from Rs 1,16,195 crore YoY. Disclaimer: Moneycontrol is a part of the Network18 group. Network18 is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.
ICICI Bank: The bank reported sharply higher standalone profit at Rs 5,511 crore in Q2FY22 against Rs 4,251.3 crore in Q2FY21, net interest income jumped to Rs 11,690 crore from Rs 9,366 crore YoY.
ABB Power Products and Systems India: The company reported sharply higher profit at Rs 34.3 crore in Q2CY21 against Rs 4.8 crore in Q3CY20, revenue fell to Rs 850.6 crore from Rs 946.3 crore YoY. Order intake was at Rs 979 crore in Q3CY21, up from Rs 890.2 crore in Q3CY20.
Tata Consumer Products: The company reported higher consolidated profit at Rs 261.4 crore in Q2FY22 against Rs 234.3 crore in Q2FY21, revenue increased to Rs 3,033.12 crore from Rs 2781.34 crore YoY.
Metropolis Healthcare: The company completed acquisition of chain of labs in South India called ‘Hitech Diagnostic Centre’.
Coforge: Net Profit was up 18.7% at Rs 146.7 crore against Rs 123.6 crore (QoQ). Revenue was up 7.4% at Rs 1,569.4 crore against Rs 1,461.6 crore (QoQ). EBIT rose 35.2% at Rs 214.9 crore against Rs 159 crore (QoQ). EBIT margin came in at 13.7% against 10.9% (QoQ). Dollar revenue was up 6.5% at USD 212.8 million against USD 199.7 million (QoQ).
Tata Elxsi: The company reported sharply higher profit at Rs 125.33 crore in Q2FY22 against Rs 78.87 crore in Q2FY21, revenue jumped to Rs 595.33 crore from Rs 430.17 crore YoY.
Minda Industries: The company approved second tranche of investment in equity shares of Strongsun Renewables, the special purpose vehicle (SPV). With this, the company holds 28.10% stake in SPV. The acquisition of shares is for availing solar power for its manufacturing units at Maharashtra.
HG Infra Engineering: The company received the provisional certificate of completion for project – Morshi- Chandur-Bazar-Achalpur section in Maharashtra, on engineering, procurement & construction (EPC) basis contract.
Dodla Dairy: The company reported lower consolidated profit at Rs 29.4 crore in Q2FY22 against Rs 42.56 crore in Q2FY21, revenue jumped to Rs 566.37 crore from Rs 460.96 crore YoY.
Gland Pharma: The company reported sharply higher consolidated profit at Rs 302 crore in Q2FY22 against Rs 218 crore in Q2FY21, revenue jumped to Rs 1,080.5 crore from Rs 831.5 crore YoY.
Pioneer Distilleries: The company appointed Gopal Kothari as Chief Financial Officer in place of Sanjoy Sarkar.
A2Z Infra Engineering: Rajesh Jain resigned as Executive Director and CEO of the company.
Crompton Greaves Consumer Electricals: The company reported higher consolidated profit at Rs 158.81 crore in Q2FY22 against Rs 141.68 crore in Q2FY21, revenue rose to Rs 1,385.12 crore from Rs 1,213.19 crore YoY.
Kirloskar Ferrous Industries: The company reported sharply higher profit at Rs 119.91 crore in Q2FY22 against Rs 65.55 crore in Q2FY21, revenue rose to Rs 958.38 crore from Rs 486.24 crore YoY.
Omkar Speciality Chemicals: The company approved fund raising of Rs 50 crore via rights issue.
Vijaya Diagnostic Centre: FMR LLC & FIL Ltd picked 0.22% stake in the company via open market transactions on October 20, increasing shareholding to 5% from 4.78% earlier.
Multi Commodity Exchange of India: The company reported lower consolidated profit at Rs 32.66 crore in Q2FY22 against Rs 58.55 crore in Q2FY21, revenue fell to Rs 83.19 crore from Rs 119.68 crore YoY.
Ami Organics: The company reported higher consolidated profit at Rs 17.47 crore in Q2FY22 against Rs 15.22 crore in Q2FY21, revenue rose to Rs 122.3 crore from Rs 91.27 crore YoY.
Tatva Chintan Pharma Chem: The company reported sharply higher consolidated profit at Rs 32.41 crore in Q2FY22 against Rs 3.55 crore in Q2FY20, revenue jumped to Rs 123.6 crore from Rs 60 crore YoY.
Huhtamaki India: The company reported lower profit at Rs 21.84 crore in Q2FY22 against Rs 36.88 crore in Q2FY21, revenue fell to Rs 668.73 crore from Rs 685.9 crore YoY.
Moneycontrol News
